title: Increased retinol binding protein in the sera of patients with severe ischemic damage of the liver after transplantation.
abstract: OBJECTIVE
  To study retinol binding protein variation in the serum of patients who have undergone liver transplantation.
  
  
  METHODS
  Retinol binding protein was retrospectively determined by the immunonephelometric method on serum from 14 patients who had undergone orthotopic liver transplantation 2 weeks after the surgery and then once a month during the first year posttransplantation. The patients were divided into two groups on the basis of early (first 10 days) postoperative graft function: group I, 6 patients with severe ischemic damage; and II 8 patients with moderate-severe liver dysfunction.
  
  
  RESULTS
  The men retinol binding protein level at one year of follow-up was persistently higher in group I than in group II (83.1 +/- 33.4 vs 44.6 +/- 20.7 mg/L, p < 0.001). Interestingly, retinol binding protein levels remained higher in patients of group I event when the other biochemical parameter of liver function returned to normal. The increase in retinol binding protein serum levels was independent of variation in other parameters of liver and kidney function, but was correlated with an increase in transthyretin and retinol levels.
  
  
  CONCLUSIONS
  Our results show a close relationship between a permanent high retinol binding protein level and severe graft injury after liver transplantation. However, the mechanism underlying the increase remains to be defined.
authors.affiliation: Division of Clinical Chemistry and Microbiology, National Cancer Institute, Milano, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Mastroianni
authors.forename: E
authors.initials: E
authors.lastname: Regalia
authors.forename: G
authors.initials: G
authors.lastname: Facchetti
authors.forename: P D
authors.initials: PD
authors.lastname: Longoni
authors.forename: F
authors.initials: F
authors.lastname: Formelli
authors.forename: A
authors.initials: A
authors.lastname: Pulvirenti
authors.forename: V
authors.initials: V
authors.lastname: Mazzaferro
mesh_terms: D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D001663:Bilirubin / Q000097:blood; D006528:Carcinoma, Hepatocellular / Q000601:surgery; D003404:Creatinine / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007511:Ischemia / Q000097:blood*; D007677:Kidney Function Tests; D008099:Liver / Q000098:blood supply*; D008103:Liver Cirrhosis / Q000209:etiology / Q000601:surgery; D008111:Liver Function Tests; D008113:Liver Neoplasms / Q000601:surgery; D016031:Liver Transplantation / Q000473:pathology* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000097:blood*; D011228:Prealbumin / Q000032:analysis; D012177:Retinol-Binding Proteins / Q000032:analysis / Q000378:metabolism*; D013997:Time Factors; D014801:Vitamin A / Q000097:blood; D005723:gamma-Glutamyltransferase / Q000097:blood
chemical_list: D011228:Prealbumin; D012177:Retinol-Binding Proteins; D014801:Vitamin A; D003404:Creatinine; D005723:gamma-Glutamyltransferase; D000410:Alanine Transaminase; D001663:Bilirubin